menu ☰
menu ˟

Cognitive and clinical outcomes of B-vitamin treatment in mild cognitive impairment

Creator:

International Journal of Geriatric Psychiatry

Type: Report
Region: Republic of Ireland
Northern Ireland
Description:

Further results from an Oxford University study in 2010 appear to suggest that B vitamins can slow mental decline in some elderly people with mild memory problems (mild cognitive impairment [MCI]).The effect is apparent in participants with high levels of an amino acid, homocysteine, in the blood. But larger trials will be necessary to confirm such a result and determine whether B vitamins can halt progression to Alzheimer’s in this group.The findings are published in the International Journal of Geriatric Psychiatry.Around one in six elderly people (70+) has MCI and experiences problems with memory, language, or other mental functions, but not to a degree that interferes with daily life. Around half of people with MCI develop dementia, mainly Alzheimer’s, within five years of diagnosis.The B vitamins folic acid, vitamin B6 and vitamin B12 are known to control levels of homocysteine in the blood, high levels of which are associated with an increased Alzheimer’s risk.To access the abstract and full text (registration or payment may be required):http://onlinelibrary.wiley.com/doi/10.1002/gps.2758/abstract

Date:

22/07/2011

Rights: Public
Suggested citation:

International Journal of Geriatric Psychiatry. (2011) Cognitive and clinical outcomes of B-vitamin treatment in mild cognitive impairment [Online]. Available from: http://publichealthwell.ie/node/99618 [Accessed: 21st September 2019].

  

View your saved citations and reading lists

Contributor:

CARDI
 
Click here to view all the resources gathered from this organisation's website.